China Shineway Pharmaceutical Stock Analysis
| CSWYY Stock | USD 19.25 0.00 0.00% |
China Shineway Pharm holds a debt-to-equity ratio of 0.004. With a high degree of financial leverage come high-interest payments, which usually reduce China Shineway's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
China Shineway's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. China Shineway's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps China Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect China Shineway's stakeholders.
For most companies, including China Shineway, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for China Shineway Pharmaceutical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, China Shineway's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that China Shineway's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which China Shineway is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of China Shineway to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, China Shineway is said to be less leveraged. If creditors hold a majority of China Shineway's assets, the Company is said to be highly leveraged.
China Shineway Pharmaceutical is fairly valued with Real Value of 19.25 and Hype Value of 19.25. The main objective of China Shineway pink sheet analysis is to determine its intrinsic value, which is an estimate of what China Shineway Pharmaceutical is worth, separate from its market price. There are two main types of China Shineway's stock analysis: fundamental analysis and technical analysis.
The China Shineway pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
China |
China Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.58. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Shineway Pharm last dividend was issued on the 12th of September 2022. China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the Peoples Republic of China and Hong Kong. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited. China Shineway operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3871 people.The quote for China Shineway Pharmaceutical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on China Shineway Pharmaceutical please contact the company at 86 31 1880 30066 or go to https://www.shineway.com.China Shineway Pharm Investment Alerts
| China Shineway Pharm generated a negative expected return over the last 90 days |
China Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 777.38 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate China Shineway's market, we take the total number of its shares issued and multiply it by China Shineway's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.China Profitablity
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.Technical Drivers
China Shineway Pharm technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.China Shineway Pharm Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as China Shineway Pharm price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
China Shineway Outstanding Bonds
China Shineway issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. China Shineway Pharm uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most China bonds can be classified according to their maturity, which is the date when China Shineway Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
China Shineway Pharm Debt to Cash Allocation
China Shineway Pharmaceutical has accumulated 24.89 M in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. China Shineway Pharm has a current ratio of 4.83, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist China Shineway until it has trouble settling it off, either with new capital or with free cash flow. So, China Shineway's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Shineway Pharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Shineway's use of debt, we should always consider it together with cash and equity.China Shineway Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the China Shineway's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of China Shineway, which in turn will lower the firm's financial flexibility.China Shineway Corporate Bonds Issued
About China Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how China Shineway prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling China shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as China Shineway. By using and applying China Pink Sheet analysis, traders can create a robust methodology for identifying China entry and exit points for their positions.
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the Peoples Republic of China and Hong Kong. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited. China Shineway operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3871 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding China Shineway to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Additional Tools for China Pink Sheet Analysis
When running China Shineway's price analysis, check to measure China Shineway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Shineway is operating at the current time. Most of China Shineway's value examination focuses on studying past and present price action to predict the probability of China Shineway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Shineway's price. Additionally, you may evaluate how the addition of China Shineway to your portfolios can decrease your overall portfolio volatility.